Abstract:A fast clearing hydrophilic near-infrared (NIR) dye ICG-Der-02 was used to constitute tumor targeting contrast agents. Cell adhesion molecule integrin av beta 3 served as the target receptor because of its unique expression on almost all sprouting tumor vasculatures. The purpose of this study was to synthesize and compare the properties of integrin av beta 3-targeted, fast clearing NIR probes both in vitro and in vivo for tumor diagnosis. ICG-Der-02 was covalently conjugated to three kinds of RGD peptide including linear, monoeric cyclic and dimeric RGD to form three RGD-based NIR probes. The integrin receptor specificities of these probes were evaluated in vitro by confocal microscopy. The dynamic bio-distribution and elimination ratse were in vivo real-time monitored by a near-infrared imaging system in normal mice. Further, the in vivo tumor targeting abilities of the RGD-based NIR probes were compared in av beta 3-positive MDA-MB-231, U87MG and alpha(v)beta 3-negtive MCF-7 xenograft mice models. Three RGD-based NIR probes were successfully synthesized with good optical properties. In vitro cellular experiments indicated that the probes have a clear binding affinity to alpha(U)beta 3-positive tumor cells, with a cyclic dimeric RGD probe owing the highest integrin affinity. Dynamic bio-distributions of these probes showed a rapid clearing rate through the renal pathway. In vivo tumor targeting ability of the RGD-based porbes was demonstrated on MDA-MB-231 and U87MG tumor models. As expected, the c(RGDyK)2-ICG-Der-02 probe displayed the highest tumor-to-normal tissue contrast. The in vitro and in vivo block experiments confirmed the receptor binding specificity of the probes. The hydrophilic dye-labeled NIR probes exhibited a fast clearing rate and deep tissue penetration capability. Further, the alpha(U)beta 3 receptor affinity of the three RGD-based NIR probes followed the order of dimer cyclic > monomer cyclic > linear. The results demonstrate potent fast clearing probes for in vivo early tumor diagnosis. Copyright (c) 2012 John Wiley & Sons, Ltd.

Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.

Synthesis of Dimeric Cyclic RGD Based Near-Infrared Probe for in Vivo Tumor Diagnosis

GSH-Activated Light-Up Near-Infrared Fluorescent Probe with High Affinity to Αvβ3 Integrin for Precise Early Tumor Identification.

High‐Performance Red/Near‐IR Carbon Dots As Fluorescence Probes for Tumor Imaging in Vivo

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Optical Imaging Of Integrin Alpha(V)Beta(3) Expression With Near-Infrared Fluorescent Rgd Dimer With Tetra(Ethylene Glycol) Linkers

Comparison of cRGDfK Peptide Probes with Appended Shielded Heptamethine Cyanine Dye ( s775z ) for Near Infrared Fluorescence Imaging of Cancer

Ανβ3 Integrin-Targeted ICG-derived Probes for Imaging-Guided Surgery and Photothermal Therapy of Oral Cancer.

Cyclic-Arginine-Glycine-Aspartic (C-Rgd) Conjugated Polymeric Micelles for SPECT/NIRF Dual-Modality Tumor Imaging

A NIR-II Fluorescent Probe for High Contrast Non-Invasive Imaging of Tumors with a High EGFR-expression

Dual‐Targeting Peptides RGD10‐NGR9‐Conjugated Lanthanide Nanoparticle@Polydopamine As Upconversion Nanoprobes for in Vivo Imaging of Lung Cancer

A Near-Infrared Fluorescent Heptamethine Indocyanine Dye With Preferential Tumor Accumulation For In Vivo Imaging

Molecular Cancer Imaging in the Second Near‐Infrared Window Using a Renal‐Excreted NIR‐II Fluorophore‐Peptide Probe

Targeted Delivery of a Γ-Glutamyl Transpeptidase Activatable Near-Infrared-Fluorescent Probe for Selective Cancer Imaging

Synthesis and Evaluation of a Novel BODIPY Fluorescent Probe Targeting Integrin Αvβ3 for Cancer Diagnosis

Integrin (αvβ3) Targeted RGD Peptide Based Probe for Cancer Optical Imaging.

A Near-Infrared Fluorescent Probe With Assembly/Aggregation-Induced Retention Effect for Specific Diagnosis of Metastasis and Image-Guided Surgery in Breast Cancer

Integrin Αvβ3-Specific Hydrocyanine for Cooperative Targeting of Glioblastoma with High Sensitivity and Specificity.

Dual-Mode Contrast Agents with RGD-Modified Polymer for Tumour-Targeted US/NIRF Imaging

125I-Labeled Octavalent-Rgd Peptide Fluorescent Nanoprobe for Dual SPECT and Optical Imaging of Integrin {alpha}v{beta}3 Receptors in Human Giloblastoma Xenografts

131)I Labeling and Bioactivity Evaluation of a Novel RGD Dimer Targeted to Integrin Αvβ3 Receptor